Colorectal Cancer

• FDA label_change · 2017-04-27
  FDA Approved: STIVARGA — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

  FDA page documents Bayer's supplemental application for Stivarga (regorafenib), indicating a label change is being sought.

• FDA label_change · 2014-12-19
  FDA Approved: CAMPTOSAR — Supplemental Application (Pharmacia & Upjohn Company LLC)

  FDA approved a supplemental application for Camptosar (irinotecan hydrochloride) submitted by Pharmacia & Upjohn Company LLC.

• FDA label_change · 2013-03-28
  FDA Approved: VECTIBIX — Supplemental Application (Amgen, Inc)

  FDA approved a supplemental application for VECTIBIX (panitumumab) filed by Amgen, Inc. The approval updates the drug's labeling to reflect …